BioNTech lifts 2021 COVID-19 vaccine output target to 2 billion doses

B

Pfizer Inc’s partner BioNTech SE has boosted the 2021 delivery target for their COVID-19 vaccine to 2 billion doses, up from 1.3 billion previously, as they add new production lines and as more doses can be extracted per vial.

Special syringes known as low dead space syringes allow for extraction of six vaccine doses from a standard vial, instead of the usual five, avoiding wasting unused liquid left in a syringe.

That would result in 1 billion people getting the designated two-dose regimen, BioNTech said on Monday in a presentation for the annual JP Morgan healthcare conference being held virtually this year due to the coronavirus pandemic.

“We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated six-dose label,” BioNTech said.

https://www.reuters.com/article/BigStory12/idUSKBN29G1DM